PROCEPT BioRobotics (PRCT) Share-based Compensation Growth (3y) (2023 - 2026)
PROCEPT BioRobotics (PRCT) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | - |
| 10 | PROCEPT BioRobotics | 958.99 Mn | 713.35 Mn | 53.95 Mn | 51.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.98% |
| Dec 31, 2025 | 287.73% |
| Sep 30, 2025 | -7.72% |
| Jun 30, 2025 | 65.65% |
| Mar 31, 2025 | 86.75% |
| Dec 31, 2024 | 81.21% |
| Sep 30, 2024 | 109.56% |
| Jun 30, 2024 | 122.50% |
| Mar 31, 2024 | 112.71% |
| Dec 31, 2023 | 102.03% |